The first patients have been dosed in a phase 3 trial of an mRNA ... vaccine developed by Pfizer and BioNTech, which may offer quicker production and greater efficacy than shots made using ...

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

Fellow big pharma company, Sanofi has also made a number of moves to bolster its R&D pipeline for mRNA vaccines – not least when it stated that it would invest €400 million each year into the ...

Approval would give Japan a home-grown mRNA vaccine of the type that have made up the bulk of its COVID inoculations so far. The vaccine known as DS-5670 is being proposed as a booster shot ...

In Ezra Klein and Derk Thompson’s new book Abundance — which maybe you’ve heard of — they tell the story of Katalin Karikó, ...

Is MRNA stock a sell? In 2020, many companies tried to develop effective coronavirus vaccines, but two ended ... Pfizer has made important moves in the past few years that could pay off down ...

RNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there ...

Ethris, a clinical-stage biotechnology company creating RNA therapeutics and vaccines, and Lonza entered a collaboration to ...

Vaccine types include live-attenuated, inactivated, subunit, conjugate, mRNA, and viral vector vaccines. Each type has unique characteristics suitable for different infectious agents and patient ...

Heidelberg biochemists and structural biologists from Shanghai unravel the roles of two key regulatory factors in mRNA ...